Xeloda Sales Data
| Rank 93 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Xeloda U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 93 ( 2) |
$194,044 | 6.52% | 60 | 1.69% |
| Q3 2013 | 95 ( 6) |
$182,175 | -2.33% | 59 | -6.35% |
| Q2 2013 | 89 (8) |
$186,517 | 6.87% | 63 | 6.78% |
| Q1 2013 | 97 (2) |
$174,526 | -2.21% | 59 | -9.23% |
| Q4 2012 | 95 | $178,469 | 1.16% | 65 | n/a |
| Q3 2012 | 95 (1) |
$176,414 | 5.28% | 65 | -1.52% |
| Q2 2012 | 96 ( ) |
$167,560 | n/a | 66 | n/a |
| Q4 2011 | 96 (5) |
$168,186 | 1.39% | 69 | n/a |
| Q3 2011 | 91 () |
$165,875 | n/a | 69 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
